人工智能应用于糖尿病并发症:一个图书识别分析
Yukun Tao1, Jinzheng Hou1, Guangxin Zhou1
1Department of Endocrinology, Air Force Medical Center, Air Force Medical University, Beijing, China.
Frontiers in artificial intelligence
|February 17, 2025
概括
人工智能 (AI) 正在推动糖尿病并发症研究. 未来的重点将是针对糖尿病视网膜病变和糖尿病足的AI,全球研究预计将增长.
科学领域:
- 医疗信息学 医疗信息学
- 人工智能的人工智能
- 图书统计学 图书统计学
背景情况:
- 人工智能 (AI) 驱动的医疗辅助技术越来越多地用于诊断,治疗和预测糖尿病并发症.
- 图书统计分析被用来绘制人工智能在糖尿病并发症中的研究格局.
研究的目的:
- 探索当前的研究趋势,并确定糖尿病并发症人工智能领域的尖端热点.
- 为科学生产,主要贡献者和新兴领域提供全面的概述.
主要方法:
- 从1988年到2024年出版的935篇文章的文献计量分析,来源于PubMed.
- 使用CiteSpace,Vosviewer和bibliometix构建知识地图,以可视化出版趋势,作者,国家,机构,期刊和关键词.
- 数据分析包括年度科学生产,作者合作,国家生产力和普遍的研究主题.
主要成果:
- 年度出版物显示出明显的上升趋势,表明研究兴趣日益增长.
- 美国,中国和印度是糖尿病并发症人工智能研究的领先国家.
- 糖尿病视网膜病变,糖尿病病和糖尿病脚病是最常被研究的并发症,机器学习,深度学习和查是关键的研究领域.
结论:
- 全球对糖尿病并发症人工智能研究的研究预计将扩大.
- 未来的研究很可能将集中在AI在糖尿病视网膜病变和糖尿病足管理中的应用上.
相关概念视频
Issues And Trends In Healthcare Delivery System
5.6K
The issues and trends in healthcare delivery are constantly changing. The COVID-19 pandemic is one recent issue that wreaked havoc on healthcare systems, causing a shortage of healthcare workers, high demand for medicines and supplies, and increased medical expenditure due to a lack of insurance. Other issues include rising healthcare costs and care fragmentation.
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
5.6K
Diabetes Mellitus: Overview and Type I Subtype
2.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.4K
Diabetes: Management and Pharmacotherapy
229
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
229
